Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

December 1 2023 - GSK pulls ahead of Pfizer in RSV vaccine market as Arexvy nears blockbuster status

GSK pulls ahead of Pfizer in RSV vaccine market as Arexvy nears blockbuster status
Pfizer cans twice-daily oral obesity program
3 medtech spinoffs that reshaped the industry in 2023
FDA starts review of Padcev/Keytruda for bladder cancer
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

GSK Pulls Ahead of Pfizer in RSV Vaccine Market as Arexvy Nears Blockbuster Status

BioSpace

Friday, December 1, 2023 - 11:30am

tags:

GSK, Pfizer, RSV, vaccines, Arexvy

Perpetual Medicines Raises $8M in Seed Funding

Finsmes

Friday, December 1, 2023 - 11:29am

tags:

Perpetual Medicines, funding, peptides, drug discovery

AbbVie Gets Phase II NSCLC Win for ADC, Looks to Accelerated Approval

BioSpace

Friday, December 1, 2023 - 11:23am

tags:

AbbVie, Teliso-V, antibody-drug conjugate, non-small cell lung cancer

Pfizer cans twice-daily oral obesity program after half of patients leave trial while once daily continues

Fierce Biotech

Friday, December 1, 2023 - 9:50am

tags:

Pfizer, obesity, clinical trials, danuglipron

Altimmune Joins Weight-Loss Race with Phase II Win, Stock Jumps on News

BioSpace

Friday, December 1, 2023 - 9:46am

tags:

Altimmune, clinical trials, obesity, GLP-1 agonist, pemvidutide

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

Medical Marketing and Media

Friday, December 1, 2023 - 9:43am

tags:

biotech stocks, AbbVie, Immunogen, M&A

Drug discovery startup Pepper Bio hopes to challenge Eroom’s law with new funding

TechCrunch

Friday, December 1, 2023 - 9:41am

tags:

Pepper Bio, drug discovery, transomics

3 medtech spinoffs that reshaped the industry in 2023, and what to expect next

Medtech Dive

Friday, December 1, 2023 - 9:38am

tags:

Medtech, spinoffs, GE Healthcare, JNJ, Danaher, Baxter, 3M, Medtronic

Pfizer site in Connecticut in line for layoffs amid $3.5B cost-cutting campaign

Fierce Pharma

Friday, December 1, 2023 - 9:36am

tags:

Pfizer, Connecticut, layoffs

FDA starts review of Padcev/Keytruda for bladder cancer

Pharmaphorum

Friday, December 1, 2023 - 9:35am

tags:

Merck, Astellas, Seagen, Padcev, bladder cancer, FDA, priority review

AstraZeneca calls off two late-stage potassium drug trials

Reuters

Friday, December 1, 2023 - 9:34am

tags:

AstraZeneca, clinical trials, Lokelma, hyperkalemia

Pharma’s engagement with healthcare providers has slipped in recent years

Clinical Trials Arena

Thursday, November 30, 2023 - 11:24pm

tags:

physicians, healthcare providers, Veeva, pharma marketing

J&J Becomes the Newest Player in the LAA Market

Medical Devices and Diagnostics Industry

Thursday, November 30, 2023 - 11:21pm

tags:

JNJ, M&A, Medtech, Penditure LAA

Samsung Bioepis, J&J Ink Settlement and License Deal for Stelara Biosimilar

BioSpace

Thursday, November 30, 2023 - 11:20pm

tags:

Samsung Bioepsis, JNJ, patents, Stelara, biosimilars, SB17

FTC chief gears up for a showdown with private equity

Medical Marketing and Media

Thursday, November 30, 2023 - 11:18pm

tags:

FTC, private equity

Lumen Bioscience bags $5.5 million to develop needle-free vaccines

Biopharma Reporter

Thursday, November 30, 2023 - 11:16pm

tags:

Lumen Biosciences, needle-free vaccines, vaccines, funding

Xenon Looks to Raise Cash for MDD Program with $300M Public Offering

BioSpace

Thursday, November 30, 2023 - 11:15pm

tags:

Xenon, major depressive disorder, stock offering

GSK CEO says RSV vaccine revenue to top 1 bln pounds in first year

Reuters

Thursday, November 30, 2023 - 11:12pm

tags:

GSK, RSV, vaccines, Emma Walmsley, Pharma CEOs

AbbVie pays $10B to acquire ImmunoGen, doubling down on red-hot ADC cancer field

Fierce Pharma

Thursday, November 30, 2023 - 10:20am

tags:

AbbVie, M&A, antibody-drug conjugate, Immunogen, Elahere, ovarian cancer

Ascendis sells Japanese rights to Skytrofa and two other hormone drugs for $70M upfront

Fierce Biotech

Thursday, November 30, 2023 - 10:19am

tags:

Ascendis, Japan, Skytrofa, growth hormone, Teijin Pharma

Pages

Latest CP Wire Articles

First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study

Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth

Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Sapio Sciences launches new drug discovery platform

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Eastman introduces new excipient to formulate poorly soluble API

Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more

PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award

Latest Pharmagather Articles

How Direct-to-Consumer Rx Platforms Help Patient Support Programs Succeed

Drug Channels

Drug Channels News Roundup, November 2023: My $0.02 on Express Scripts’ Cost-Based Pricing, Mark Cuban vs. PBMs, Dual-WAC Strategies, Pharmacy Shakeout, and Adam vs. Rocky

Drug Channels

Simplify and Accelerate Benefits Verification with a Fully Integrated, Adaptable Platform

Drug Channels

Medicare Part D in 2024: Mapping Large Chains' Position in 2024’s Preferred Pharmacy Networks

Drug Channels

Drug Channels Outlook 2024 (NEW Live Video Webinar)

Drug Channels

Four Trends That Are Shaping the Future of Market Access

Drug Channels

FDA’s OPDP Issues Two New Untitled Letters

eye on fda

Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies

Drug Channels

Is Your Hub Partner Missing the Therapeutic Area Expertise You Need?

Drug Channels